Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6199607

Cn1cnc(-c2ccc(S(=O)(=O)N3CCC(Nc4nc(N)c(C(=O)c5c(F)cccc5F)s4)CC3)cc2)c1.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 6/20 0.46
CCND1 P24385 6/20 0.46
CCNT1 O60563 4/20 0.46
CDK9 P50750 4/20 0.46
CDK6 Q00534 4/20 0.46
CDK11A Q9UQ88 4/20 0.46
CDK2 P24941 7/20 0.42
CDK1 P06493 2/20 0.42
IKBKB O14920 4/20 0.41
CDK5 Q00535 2/20 0.41
CDK5R1 Q15078 2/20 0.41
CCR6 P51684 1/20 0.39
CCNA2 P20248 4/20 0.39
CCNK O75909 1/20 0.39
CDK12 Q9NYV4 1/20 0.39
CHUK O15111 1/20 0.38
MAPK8 P45983 1/20 0.38
MAPK9 P45984 1/20 0.38
MAPK10 P53779 1/20 0.38
MAPK11 Q15759 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6198507 0.88 CDK4 (0.43) CDK4CCND1CCNT1CDK9CDK6
Trifluoroacetic Acid SCHEMBL6408250 0.86 CDK4 (0.44) CDK4CCND1CCNT1CDK9CDK6
Trifluoroacetic Acid SCHEMBL6197870 0.84 CDK2 (0.46) CDK4CCND1CCNT1CDK9CDK6
SCHEMBL6193029 0.84 CDK4 (0.49) CDK4CCND1CCNT1CDK9CDK6
Trifluoroacetic Acid SCHEMBL6198312 0.84 CDK4 (0.46) CDK4CCND1CCNT1CDK9CDK6
Trifluoroacetic Acid SCHEMBL6410574 0.83 CDK4 (0.42) CDK4CCND1CCNT1CDK9CDK6
SCHEMBL6199575 0.82 CDK4 (0.52) CDK4CCND1CCNT1CDK9CDK6
SCHEMBL6407196 0.82 CDK4 (0.52) CDK4CCND1CCNT1CDK9CDK6
SCHEMBL6193981 0.82 CDK5 (0.52) CDK4CCND1CCNT1CDK9CDK6
Trifluoroacetic Acid SCHEMBL6416198 0.82 CDK4 (0.42) CDK4CCND1CCNT1CDK9CDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1597256-A1 N-HETEROCYCLYL-SUBSTITUTED AMINO-THIAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS PFIZER INC. (US) 2005-11-23 EP disclosed
US-20050101595-A1 N-containing cycloalkyl-substituted amino-thiazole derivatives and pharmaceutical compositions for inhibiting cell proliferation and methods for their use PFIZER INC. 2005-05-12 US disclosed
WO-2004074283-A1 N-HETEROCYCLYL-SUBSTITUTED AMINO-THIAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS PFIZER INC. (US) 2004-09-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050101595-A1 N-containing cycloalkyl-substituted amino-thiazole derivatives and pharmaceutical compositions for inhibiting cell proliferation and methods for their use CCNI, MKI67, TK1 CDK4 78/4885CCND1 61/4885CCNT1 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.